Lexicon Pharmaceuticals
LXRX
#7142
Rank
ยฃ0.38 B
Marketcap
ยฃ1.05
Share price
-1.41%
Change (1 day)
106.29%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -ยฃ0.15

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.14. In 2024 the company made an earnings per share (EPS) of -ยฃ0.48 an increase over its 2023 EPS that were of -ยฃ0.60.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.15-69.12%
2024-ยฃ0.48-20%
2023-ยฃ0.6031.15%
2022-ยฃ0.46-0%
2021-ยฃ0.4610.91%
2020-ยฃ0.41-145.08%
2019ยฃ0.92-206.09%
2018-ยฃ0.86-5.74%
2017-ยฃ0.92-10.95%
2016-ยฃ1.032640%
2015-ยฃ0.03753-96.34%
2014-ยฃ1.02-2.53%
2013-ยฃ1.05-9.09%
2012-ยฃ1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-ยฃ57.58 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ32.61-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ4.46 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ2.04-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ13.02-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.41 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ3.36-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.79-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.56 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA